ru-28362 has been researched along with 21-deoxycortisol in 1 studies
Studies (ru-28362) | Trials (ru-28362) | Recent Studies (post-2010) (ru-28362) | Studies (21-deoxycortisol) | Trials (21-deoxycortisol) | Recent Studies (post-2010) (21-deoxycortisol) |
---|---|---|---|---|---|
175 | 0 | 3 | 78 | 3 | 21 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beck, JS; Brown, RA; Deraedt, R; Potts, RC | 1 |
1 other study(ies) available for ru-28362 and 21-deoxycortisol
Article | Year |
---|---|
Suppression of growth of PHA-stimulated human lymphocytes by a novel steroid (RU 28 362) lacking the 21-OH group.
Topics: Androstanols; Betamethasone; Cell Division; Cortodoxone; Humans; Hydrocortisone; Immunosuppressive Agents; In Vitro Techniques; Lymphocyte Activation; Lymphocytes; Phytohemagglutinins; Receptors, Immunologic; Receptors, Interleukin-2 | 1987 |